3Q 2023 Brand-generic pipeline
October 12, 2023 · Clinical Team
The following list represents a summary of new medications approved by the U.S. Food and Drug Administration (FDA) and first-time generics or brand alternatives that potentially may be prescribed for the treatment of a workers’ compensation or auto injury. Off-label use for the treatment of conditions outside of FDA-approved indications may not be supported by medical treatment guidelines or Optum Workers’ Compensation and Auto No-Fault. Please note this list is not all-inclusive.
If you have any questions, please contact our Clinical Services team at 1-877-275-7674 ext. 8612.
Disclaimer: The information contained herein is provided as-is for informational purposes only and does not constitute medical advice or formal utilization review. This document should not be used in place of a licensed medical practitioner’s independent medical examination, opinion or practice. Optum makes no warranties or representations as to the accuracy or effectiveness of any medical treatment guidelines, formularies or FDA-approved indications that are published after the date of this document.